AG
ENFN

Algert Global’s Enfusion, Inc. ENFN Stock Holding History

Algert Global’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,450
Closed -$139K – 1286
2023
Q3 		$139K Buy
+15,450
New +$147K 0.01% 1005
2022
Q4 		– Sell
-10,610
Closed -$131K – 1320
2022
Q3 		$131K Buy
+10,610
New +$129K 0.01% 1084

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Algert Global's ENFN Position: Q4 2023 in Review

Algert Global sold out of Enfusion, Inc. (ENFN) in Q4 2023, closing a stake of 15,450 shares — an estimated $139K sold.

Algert Global first reported a position in ENFN in Q3 2022 and held it in 2 quarters. The position peaked at $139K in Q3 2023. 76 funds tracked by Wall St. Rank hold ENFN as of Q4 2023.

  • Algert Global reported no remaining Enfusion, Inc. position as of Q4 2023 after selling out during the quarter.
  • Algert Global sold 15,450 Enfusion, Inc. shares in Q4 2023, an estimated $139K.
  • Algert Global first reported a position in Enfusion, Inc. in Q3 2022 and held it in 2 quarters.
  • Algert Global's Enfusion, Inc. position peaked at $139K in Q3 2023.
  • 76 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q4 2023.

Based on Algert Global's 13F filing for Q4 2023, filed 14 Feb 2024.